- Home
- HTLD vs LTGO Comparison
HTLD vs LTGO Comparison
Compare HTLD & LTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HTLD | LTGO |
|---|---|---|
| Founded | 1978 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 1995 | 2026 |
Fundamental Metrics
Financial Performance| Metric | HTLD | LTGO |
|---|---|---|
| Price | $11.16 | $15.61 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $13.20 | ★ $52.25 |
| AVG Volume (30 Days) | ★ 670.2K | 308.4K |
| Earning Date | 10-30-2026 | 11-19-2026 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $805,709,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.43 | N/A |
| P/E Ratio | $162.14 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.00 | $14.60 |
| 52 Week High | $16.64 | $25.93 |
Technical Indicators
Market Signals| Indicator | HTLD | LTGO |
|---|---|---|
| Relative Strength Index (RSI) | 35.57 | 37.24 |
| Support Level | $10.67 | N/A |
| Resistance Level | $11.48 | $20.49 |
| Average True Range (ATR) | 0.34 | 1.36 |
| MACD | -0.01 | -0.34 |
| Stochastic Oscillator | 11.83 | 19.54 |
Price Performance
Historical ComparisonAbout HTLD Heartland Express Inc.
Heartland Express Inc, along with its subsidiaries, operates as a short, medium, and long-haul truckload carrier and transportation services provider. It mainly provides nationwide asset-based dry van truckload service for shippers across the United States, along with cross-border freight and other transportation services offered through third-party partnerships in Mexico. The group operates under the brand names of Heartland Express, Millis Transfer, Smith Transport, and CFI (for services within Mexico).
About LTGO Latigo Biotherapeutics Inc. Common Stock
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.